Sulfasalazine

In some countries, this medicine may only be approved for veterinary use.

In the US, Sulfasalazine (sulfasalazine systemic) is a member of the following drug classes: 5-aminosalicylates, sulfonamides and is used to treat Alopecia, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Juvenile Rheumatoid Arthritis, Lymphocytic Colitis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance and Uveitis.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A07EC01

CAS registry number (Chemical Abstracts Service)

0000599-79-1

Chemical Formula

C18-H14-N4-O5-S

Molecular Weight

398

Therapeutic Categories

Antibacterial: Sulfonamide

Disease-modifying antirheumatic drug, DMARD

Chemical Name

Benzoic acid, 2-hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]-

Foreign Names

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web4)